In 2025, Century Healthcare witnessed a concentrated surge of R&D achievements, obtaining four Class‑III medical device registration certificates within one year, which fully demonstrates the enterprise’s solid innovation capability and leading position in the industry.
Among them, both the Liangshian® Trifocal‑Plus Intraocular Lens and Wanshian®‑Ultra‑EDoF Intraocular Lens are China’s first innovative medical devices in their respective fields, reflecting the company’s cutting‑edge layout in high‑end ophthalmic consumables. Meanwhile, the orthokeratology lens optimized by artificial‑intelligence‑based algorithms, as well as the Class‑III registration certificate for “Collagen Dressing” obtained by its wholly‑owned subsidiary Hainan Aimeili, have further enriched the product pipeline. Years of technological accumulation have borne fruit at this moment, marking that Century Healthcare has steadily joined the ranks of China’s powerful medical‑device R&D‑oriented enterprises.
